Eye Patch Therapy for Central Serous Retinopathy (CSR)

Central Serous Retinopathy (CSR) Clinical Trial

Official title: Eye Patching as a Potential Treatment Modality for and a Possible Etiological Insight on Central Serous Retinopathy

Status Completed

Clinical Trial Summary

First, this study will investigate the viability of 24-hour eye patching as a potential treatment modality for CSR. Second, this study will assess a potential physiologic explanation for CSR, namely if inhibition of photic stimulation of the diseased retina will aid in ameliorating disease severity and disease duration.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

• Central Serous Chorioretinopathy
• Central Serous Retinopathy (CSR)
• Retinal Diseases

• NCT number: NCT02036632
• Study type: Interventional
• Source: Washington University School of Medicine
• Status: Completed
• Phase: Phase 1
• Start date: November 2012
• Completion date: January 2015